13 August 1993 New stable tunable solid-state dye laser in the red
Author Affiliations +
Abstract
A red perylene derivative was impregnated into a composite silica-gel glass, and characterized as a dye laser material. The absorption spectrum in the range 480 - 600 nm belongs to the S0 - S1 electronic transition, with a structure reflecting the perylene skeletal vibrations, of typical energy 1100 - 1200 cm-1. An additional peak between 400 and 460 nm belongs to the S0 - S2 transition. The fluorescence exhibits a mirror image relative to the S0 - S1 absorption, with a Stokes shift of about 40 nm for the 0 - 0 transition. Laser tunability was obtained in the range 605 - 630 nm using a frequency-doubled Nd:YAG laser for pumping ((lambda) equals 532 nm). This wavelength range is important for medical applications, such as photodynamic therapy of some cancer tumors. Maximum laser efficiency of approximately 2.5% was obtained at 617 nm. Maximum output was approximately 0.36 mJ/pulse at a repetition rate of 10 Hz. Minimum laser threshold obtained was 0.45 mJ/pulse. The medium losses are attributed to an excited-state singlet-singlet absorption, with an upper limit cross-section of approximately 2.5 X 10-16 cm2. The laser output was stable over more than approximately 500,000 pulses, under excitation with the green line of a copper vapor laser (510 nm), of energy density approximately 40 mJ/cm2 per pulse. Good prospects exist for a considerable enhancement in laser output efficiency.
© (1993) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Raz Gvishi, Raz Gvishi, Renata Reisfeld, Renata Reisfeld, Zeev Burshtein, Zeev Burshtein, Eli Miron, Eli Miron, "New stable tunable solid-state dye laser in the red", Proc. SPIE 1972, 8th Meeting on Optical Engineering in Israel: Optoelectronics and Applications in Industry and Medicine, (13 August 1993); doi: 10.1117/12.151121; https://doi.org/10.1117/12.151121
PROCEEDINGS
10 PAGES


SHARE
RELATED CONTENT


Back to Top